By

Sara Dagen

UF Researcher Will Lead CureSearch for Children’s Cancer $1 Million Gift To Support Cutting-Edge Immunotherapy Trial for Pediatric High-Grade Glioma

CureSearch for Children’s Cancer has received a $1 million gift from the Norcross Family Foundation in support of a first-in-human, phase I/II clinical trial testing innovative personalized immunotherapy for pediatric high-grade gliomas, the primary cause of death in children with brain tumors. The project is funded through a CureSearch Catapult Award granted to pediatric oncologist Elias Sayour, MD, Ph.D. at the University of Florida.

Field-Testing Natural Compounds To Fight HLB

Field tests of numerous antibacterial products and plant-derived compounds are underway with the goal of eliminating the HLB-causing bacteria in citrus and reversing plant damage to restore tree health.

UF Researchers Receive $1.46 Million Grant To Implement Alternatives to Opioids Program

Imagine a world where emergency room patients and providers have access to a menu of pain management treatment options that include a blend of traditional and integrative techniques. This is the vision held by a team at the University of Florida College of Medicine – Jacksonville looking to create a new way of caring for patients with a variety of pain conditions.

SARS-CoV-2 Spike Protein Licensed by Oragenics From the NIH Demonstrates Protective Immunity in Mice

UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announces that the stabilized pre-fusion spike protein CoV-2 S-2P created by the National Institutes of Health (“NIH”) and licensed by the Company demonstrates protective immunity in immunized mice challenged with mouse-adapted SARS-CoV-2 virus.